New Tool May Help Prioritize High-Risk Infants for RSV Immunization
American Thoracic Society (ATS)Pediatric Impact of COVID-19 and Other Respiratory Infections Clinical Prediction Tool for Prioritizing Respiratory Syncytial Virus Prevention Products for High-Risk Infants During Current Limited Availability of Nirsevimab in the United States